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Abstract
Introduction:  Erectile  dysfunction  (ED)  is  the  inability  to  achieve  or  maintain  an  erection  for
satisfactory  sexual  activity.  Recent  studies  have  shown  an  association  between  ED  and  chronic
obstructive  pulmonary  disease  (COPD).  However,  this  issue  is  often  ignored.  We  aimed  to  eval-
uate the  ED  prevalence  in  COPD  patients  and  its  risk  factors  and  to  study  the  impact  of  dyspnea
in sexual  activity.
Methods:  Cross-sectional  study  that  included  sexually  active  male  patients  with  COPD.  The
International  Index  of  Erectile  Function  (IIEF-5)  questionnaire  evaluated  ED  and  the  Respira-
tory Experiences  with  Sexuality  Proﬁle  (RESP)  was  used  to  evaluate  the  impact  of  dyspnea  on
sexual activity.  Risk  factors  for  mild-moderate  or  moderate  ED  were  determined  using  logistic
regression.
Results: 84  patients  were  consecutively  assessed  for  eligibility,  67  were  included  (median  age:
65 years,  13%  never-smokers).  Twenty  two  percent  had  COPD  2011-GOLD  A;  22%  GOLD  B,
14% GOLD  C  and  42%  GOLD  D.  Fifty-eight  patients  (87%)  had  some  degree  of  ED:  26  (45%)
mild, 20  (34%)  mild-moderate  and  12  (21%)  moderate  ED.  ED  occurred  in  all  GOLD  stages  of
COPD, mainly  in  GOLD  B  and  D  stages.  Higher  CAT  score  was  independently  associated  to  mild-
moderate/moderate  ED.  Most  patients  (85%)  reported  dyspnea  during  their  sexual  activity  but
72% had  never  talked  about  it  with  their  physician. Institution where the study was performed:  Centro Hospitalar Vila Nova de Gaia/Espinho, Vila Nova de Gaia, Portugal.
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http://dx.doi.org/10.1016/j.rppnen.2017.04.005
2173-5115/© 2017 Sociedade Portuguesa de Pneumologia. Published by Elsevier Espan˜a, S.L.U. This is an open access article under the CC
BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
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Conclusions:  ED  is  highly  prevalent  among  COPD  patients  and  it  is  more  severe  in  patients  with
higher CAT  scores.  Dyspnea  affects  their  sexual  activity  but  this  is  not  a  topic  often  discussed
between patients  and  doctors,  something  which  needs  to  be  improved.
© 2017  Sociedade  Portuguesa  de  Pneumologia.  Published  by  Elsevier  Espan˜a,  S.L.U.  This  is  an
open access  article  under  the  CC  BY-NC-ND  license  (http://creativecommons.org/licenses/by-
nc-nd/4.0/).
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hronic  obstructive  pulmonary  disease  (COPD)  is  a  common
reventable  and  treatable  disease  characterized  by  persis-
ent  respiratory  symptoms  and  airﬂow  limitation.1 However,
OPD  is  not  only  a  pulmonary  disease  but  also  a  chronic  ill-
ess  associated  with  systemic  inﬂammation  and  with  various
omorbidities  involving  multiple  organs.1--3
Erectile  dysfunction  (ED)  is  a  condition  of  inability  to  per-
istently  reach  and/or  maintain  an  adequate  and  necessary
rection  to  have  satisfactory  sexual  activity.4
GOLD  guidelines  state  that  sexual  activity  should  be  eval-
ated  in  all  COPD  patients,  but  they  do  not  include  ED  as
ne  of  the  possible  comorbidities  of  COPD.1 However,  some
tudies  have  reported  ED  as  a  common  comorbidity  in  COPD
atients  but  this  is  still  an  under-researched  area.5--8 More-
ver,  the  information  about  the  impact  of  the  respiratory
ymptoms  on  sexual  activity  among  COPD  patients  is  sparse.9
The  aims  of  this  study  were  to  determine  the  prevalence
f  ED  among  patients  with  COPD,  to  investigate  the  COPD
atients’  characteristics  associated  with  ED  and  the  impact
f  COPD  symptoms  on  sexual  activity  and,  therefore,  draw
ttention  to  this  issue.
ethods
tudy  design
 cross  sectional  study  was  conducted  on  COPD  outpatients
ollowed  in  the  Pulmonology  department  of  a  Portuguese
ospital,  Centro  Hospitalar  Vila  Nova  de  Gaia/Espinho.
Inclusion  criteria  were:  being  male,  having  a  diagnosis
f  COPD  and  having  had  sexual  relations  in  the  previous
 months.  The  exclusion  criteria  were:  having  ED  caused
y  structural  or  anatomic  alterations  or  having  any  COPD
xacerbation  in  the  previous  month.  Patients  were  included
onsecutively  during  a  6-month  period.
ata  collection
 booklet  containing  a  questionnaire  divided  into  two  parts
as  used.  The  ﬁrst  part  of  the  questionnaire  was  adminis-
ered  by  a  medical  doctor.  It  evaluated  several  variables,
uch  as  demographic  data,  marital  status,  level  of  edu-
ation,  smoking  status,  modiﬁed  Medical  Research  Council
yspnea  Scale  (mMRC),10 COPD  Assessment  Test  (CAT)11
core,  the  levels  of  anxiety  and  depression  according  to
he  Hospital  Anxiety  and  Depression  Scale  (HADS),12 co-
orbidities  and  medication.
R
A
1The  second  part  of  the  questionnaire  was  ﬁlled  out  by  the
atient  alone  in  the  outpatient  room  and  included  the  short
ersion  of  the  International  Index  of  Erectile  Function  (IIEF-
)13 to  evaluate  ED  and  the  Respiratory  Experiences  with
exuality  Proﬁle  (RESP)9 to  assess  the  impact  of  dyspnea  on
exual  activity.
On  the  same  day  that  the  questionnaire  was  admin-
stered,  all  patients  had  a  pulmonary  function  test  using
 spirometer  (MasterScopeTM,  CareFusion,  Höchberg,  Ger-
any).
The  study  was  approved  by  the  Medical  Ethical  Commit-
ee  of  Centro  Hospitalar  Vila  Nova  de  Gaia/Espinho  and  all
atients  signed  an  informed  consent  form  prior  to  the  study.
eﬁnitions
OPD  was  deﬁned  as  the  presence  of  a  post-bronchodilator
orced  expiratory  volume  in  1  s (FEV1)  over  forced  vital
apacity  (FVC)  ratio  below  0.70.1 COPD  stages  were  deﬁned
ccording  2011  GOLD  guidelines.14
Comorbidity  was  deﬁned  as  the  presence  of  one  or  more
iseases,  except  COPD,  that  could  be  caused  by  or  be
irectly  related  to  COPD,  regardless  of  whether  it  was  part
f  the  natural  spectrum  of  COPD.15
ED  was  deﬁned  according  to  the  IIEF-5  score.13 The  IIEF-5
uestionnaire  has  a  maximum  score  of  25  points  (1--7  points:
evere  ED;  8--11:  moderate  ED;  12--16  points:  mild-moderate
D;  17--21:  mild  ED;  22--25  points:  no  ED)  (Appendix  A).
tatistical  analysis
he  age-adjusted  prevalence  was  calculated  by  the  direct
ethod,  assuming  the  total  study  population  as  standard.
Descriptive  statistics  of  the  variables  of  interest  were
xpressed  as  absolute  and  relative  frequencies  or  mean  and
tandard  deviation.  Chi  squared  and  Mann--Whitney  U  test
ere  used  to  compare  groups.  The  strength  of  the  asso-
iation  between  IIEF-5  score  and  the  other  medical  scores
as  evaluated  by  the  Pearson  or  Spearman-rank  correlation
oefﬁcient,  as  appropriate.
Logistic  regression  was  used  to  identify  the  risk  factors
or  ED  among  COPD  patients.
All  statistical  analyses  were  carried  out  using  the  IBM  SPSS
tatistics  for  Macintosh,  version  22.0.  (Armonk,  NY,  USA:  IBM
orp).  The  signiﬁcance  level  was  set  at  0.05.esults
 total  of  84  patients  were  assessed  for  eligibility.  Of  these,
7  were  excluded  from  analysis  due  to:  refusal  to  participate
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Table  1  Demographic  and  clinical  characteristics  of  the  patients  and  univariate  analysis  of  factors  associated  to  the  presence
of erectile  dysfunction  in  these  patients.
Characteristics  Total  (n  =  67)  Univariate  analysis
No  ED  (n  =  9) ED  (n  =  58)  p  value
Age  (median  [IQR])  65  (58--71)  61  (53--64)  66  (59--72)  0.038
Smoking status  (n  [%])
Smokers  14  (21)  2  (22)  12  (21) 0.681
Ex-smokers  44  (66)  5  (56)  39  (67)
Never-smokers  9  (13)  2  (22)  7  (12)
Level of  education  (n  [%])
Less  than  high  school  graduate 55  (82) 6  (67) 49  (85) 0.383
High school  graduate  9  (13)  2  (22)  7  (12)
More than  high  school  graduate  3  (5)  1  (11)  2  (3)
Marital status  (n  [%])
Married  or  living  with  a  partner  53  (79)  6  (67)  47  (81) 0.382
Not living  with  a  partner  14  (21)  3  (33)  11  (19)
Body mass  index  (median  [IQR])  25.9  (23.5--29.8)  25.0  (21.9--25.8)  26.9  (23.6--30.9)  0.079
mMRC score  (n  [%])
0--1 38  (57) 8  (89) 30  (52) 0.037
≥2 29 (43) 1  (11) 28  (48)
CAT score  (median  [IQR])  11  (7--17)  6  (3--12)  12  (9--17)  0.015
FEV1, %  predicted  (median  [IQR])  48  (36--63)  44  (34--65)  48  (35--64)  0.720
COPD GOLD  stage  (2011)  (n  [%])
GOLD  A  15  (22)  4  (45)  11  (19) 0.147
GOLD B  15  (22)  0  (0)  15  (26)
GOLD C  9  (14)  2  (22)  7  (12)
GOLD D  28  (42)  3  (33)  25  (43)
Long term  oxygen  therapy  (n  [%])  18  (27)  0  (0)  18  (31)  0.048
HADS anxiety  score  (median  [IQR])  6  (3--9)  7  (4--10)  6  (3--9)  0.606
HADS depression  score  (median  [IQR])  3  (2--6)  2  (1--4)  4  (2--7)  0.032
Comorbidities  (n  [%])
Arterial  hypertension  32  (48)  2  (22)  30  (52)  0.153
Dyslipidemia  26  (39)  2  (22)  24  (41)  0.465
Ischemic disease  26  (39)  2  (22)  24  (41)  0.465
Diabetes mellitus  14  (21)  2  (22)  12  (21)  0.916
Heart failure  11  (16)  0  (0)  11  (19)  0.336
OSAS 2  (3)  0  (0)  2  (3)  0.748
Medications  that  could  cause  ED  (n  [%])
Thiazide  9  (13)  1  (11)  8  (14)  0.653
Omeprazole  9  (13)  2  (22)  7  (12)  0.597
Beta-blockers  9  (13)  0  (0)  9  (16)  0.341
Digoxin 4  (6)  0  (0)  4  (7)  0.554
SSRI 3  (5)  0  (0)  3  (5)  0.644
Finasteride  2  (3)  1  (11)  8  (14)  0.653
Verapamil 1  (2)  0  (0)  1  (2)  0.866
IQR: interquartile range; mMRC: Modiﬁed British Medical Research Council; CAT: Chronic Obstructive Pulmonary Disease Assessment Test;
obstr
; SSR
2FEV1: forced expiratory volume in the ﬁrst second; COPD: chronic 
OSAS: obstructive sleep apnea syndrome; ED: erectile dysfunction
(n  =  6),  having  no  sexual  relations  in  the  previous  6  months
(n  =  6),  having  a  COPD  exacerbation  in  the  previous  month
(n  =  3)  and  having  ED  due  to  anatomic  alterations  (n  =  2).
The  characteristics  of  the  67  patients  included  in  the
study  are  presented  in  Table  1.  Patients  had  a  median  age
of  65  years  and  most  (66%)  were  ex-smokers.
p
i
auctive lung disease; HADS: Hospital Anxiety and Depression Scale;
I: selective serotonin reuptake inhibitor.
Regarding  COPD  stage,  22%  of  the  patients  were  GOLD  A,
2%  were  GOLD  B,  14%  were  GOLD  C  and  42%  were  GOLD  D.There  was  no  comorbid  disease  in  19  (28%)  of  the
atients.  The  remaining  patients  had  at  least  one  comorbid-
ty,  mostly  arterial  hypertension  (48%),  dyslipidemia  (39%)
nd  ischemic  disease  (39%).  Forty-one  patients  (61%)  had  no
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Table  2  Multiple  logistic  regression  model  to  identify  factors  associated  to  mild-moderate  or  moderate  erectile  dysfunction
among COPD  patients.
Variables  Coefﬁcients  Standard  errors  p  value  OR  (95%  CI)
Constant  −1.927  0.663  0.004  --
mMRC score  ≥2  1.061  0.584  0.069  2.889  (0.919--9.082)
CAT score  0.116  0.053  0.029  1.123  (1.012--1.247)
Obstructive Pulmonary Disease Assessment Test; OR: odds ratio; CI:
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conﬁdence interval.
edication  that  could  cause  ED.  None  of  the  patients  was
aking  any  medication  for  ED.
According  to  the  IIEF-5  score,  58  (87%)  patients  had  ED
ith  varying  degrees:  26  (45%)  mild,  20  (34%)  mild  to  moder-
te  and  12  (21%)  moderate  ED.  There  were  no  patients  with
evere  ED.  The  age-adjusted  prevalence  of  ED  was  80%.
The  patient  characteristics  associated  to  the  presence
f  ED  are  shown  in  Table  1.  Patients  with  ED  were  signiﬁ-
antly  older  (66  vs.  61,  p  =  0.038),  had  more  frequently  an
MRC  score  ≥2  (48  vs.  11%,  p  =  0.037),  a  higher  median  CAT
core  (12  vs.  6,  p  =  0.015)  and  a  higher  median  HADS  depres-
ion  score  (4  vs.  2,  p  =  0.032).  Those  patients  were  more
requently  receiving  long  term  oxygen  therapy  (31%  vs.  0%,
 =  0.048).
As  the  number  of  patients  without  ED  was  small,  logis-
ic  regression  was  not  performed.  Instead,  we  divided
ur  population  into  2  groups  (no  ED/mild  ED  versus  mild-
oderate/moderate  ED)  and  performed  a  logistic  regression
o  evaluate  risk  factors  for  mild-moderate  or  moderate  ED
n  =  32)  (Table  2).  The  ﬁnal  model  identiﬁed  the  CAT  score
o  be  positively  associated  with  mild-moderate  or  moderate
D  (OR  =  1.123  [1.012--1.247]).  That  is,  for  each  increase  of
 point  in  CAT  score,  the  odds  of  mild-moderate  or  mod-
rate  ED  increase  112%.  Moreover,  mMRC  score  ≥2  tended
o  be  positively  associated  with  mild-moderate  or  moderate
D,  although  it  was  not  statistically  signiﬁcant  (OR  =  2.889
0.919--9.082]).  Therefore,  since  the  sample  is  small  and  the
 value  for  mMRC  is  close  to  0.05,  we  decided  to  include
MRC  score  in  the  ﬁnal  model.
We  evaluated  the  correlation  between  IIEF-5  score  and
ge,  mMRC  score,  CAT  score,  HADS  score  and  percentage
redicted  FEV1.  Despite  being  signiﬁcant  for  age,  mMRC,
AT  and  HADS  depression  score,  it  was,  nonetheless,  a  weak
orrelation  (r  <  0.5).
The  presence  and  the  degree  of  ED  according  to  GOLD
tages  are  presented  in  Fig.  1.  GOLD  B  and  GOLD  D  patients
ad  more  frequently  mild-moderate  or  moderate  ED.  In
ddition  to  having,  by  deﬁnition,  a  higher  mMRC  and/or
AT  score,  GOLD  B  and  GOLD  D  patients  had  a  higher  HADS
epression  score  (5  [3--7]  vs.  3  [1--4]  points,  p  =  0.013)  and
 higher  prevalence  of  arterial  hypertension  (61%  vs.  25%,
 =  0.001)  and  dyslipidemia  (49%  vs.  21%,  p  =  0.036)  than
OLD  A  and  GOLD  C  patients.  All  GOLD  B  patients  had
ome  degree  of  ED.  These  patients  had  arterial  hyperten-
ion  more  frequently  (GOLD  A  =  33%,  GOLD  B:  60%,  GOLD
:  11%  and  GOLD  D:  49%,  p  =  0.031)  as  well  as  dyslipidemia
GOLD  A  =  27%,  GOLD  B:  73%,  GOLD  C:  11%  and  GOLD  D:  36%, =  0.009).  They  also  more  frequently  took  beta-blockers
GOLD  A  =  7%,  GOLD  B:  33%,  GOLD  C:  0%  and  GOLD  D:  11%,
 =  0.048)  and  thiazides  (GOLD  A  =  13%,  GOLD  B:  33%,  GOLD
:  0%  and  GOLD  D:  7%,  p  =  0.041).
r
b
sigure  1  Prevalence  and  degree  of  erectile  dysfunction
ccording  to  the  GOLD  stages.
Regarding  the  impact  of  dyspnea  in  sexual  activity  of
OPD  patients,  the  answers  to  the  four  questions  of  RESP
uestionnaire  are  shown  in  Fig.  2.  Thirty-nine  percent  of  the
atients  reported  having  breathing  difﬁculties  during  their
exual  activity  often  or  frequently  and  73%  reported  that
he  breathing  difﬁculties  during  sexual  activity  did  not  allow
hem  to  be  as  sexually  active  as  they  would  like.  Neverthe-
ess,  24%  of  the  patients  reported  that  they  never  talked
bout  this  topic  with  their  partner  and  72%  of  the  patients
ever  talked  about  it  with  their  physician.
iscussion
rectile  dysfunction  is  an  underestimated  problem  in
OPD  patients.  The  mechanism  through  which  COPD  can
ead  to  ED  is  not  yet  fully  understood.  Possible  mecha-
isms  are  smoking,4 systemic  inﬂammation  and  endothelial
ysfunction,7 chronic  hypoxia,16 hormonal  imbalance,7 mus-
ular  weakness,17 decreased  exercise  intolerance17 and  fear
f  dyspnea.17
Our  study  showed  an  age-adjusted  prevalence  of  ED
mong  COPD  patients  of  80%.  This  prevalence  is  higher  than
he  reported  age-adjusted  prevalence  of  ED  in  Portuguese
eneral  population  (48.1%)18 and  is  also  higher  than  the
eported  prevalence  of  ED  among  patients  with  diabetes
71%),  arterial  hypertension  (67%)  or  even  among  patients
ith  both  diseases  (77%).19 However,  while  the  association
etween  diabetes  or  arterial  hypertension  and  ED  is  widely
nown,  the  association  between  COPD  and  ED  is  still  poorly
ecognized.
The  ﬁrst  data  suggesting  that  sexual  dysfunction  could
e  linked  to  COPD  was  published  in  1982.20 Since  then,  few
tudies  have  tried  to  prove  this  association.5--8 They  have
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reported  a  prevalence  of  ED  among  COPD  between  72%  and
87%,  which  is  in  line  with  our  ﬁndings.  The  variations  among
studies  can  be  explained  by  differences  in  the  methodology
used  to  evaluate  ED.
We  found  no  severe  ED  in  our  population.  This  can  be
explained  by  the  possible  exclusion  of  these  patients  in  the
category  of  not  having  sexual  relations  in  the  previous  6
months  or  for  refusal  to  participate  in  this  study  because
of  embarrassment  about  their  condition.  Nevertheless,  the
degree  of  ED  was  more  severe  in  COPD  patients  GOLD  B  and
GOLD  D,  which  may  be  due  to  worse  respiratory  symptoms
and  to  more  frequent  cardiovascular  comorbidities,  par-
ticularly  arterial  hypertension  (p  =  0.001)  and  dyslipidemia
(p  =  0.036).  Interestingly,  all  GOLD  B  patients  had  ED,  which
can  be  explained,  at  least  in  part,  by  the  higher  prevalence
of  cardiac  comorbidities  and  a  higher  use  of  beta-blockers
and  thiazides.  This  is  in  agreement  with  previous  studies  that
reported  a  higher  prevalence  of  comorbidities  and  persistent
systemic  inﬂammation  in  GOLD  B  patients.21 Comorbidities,
medicines  and  systemic  inﬂammation  can  all  contribute  to
ED.
In  the  present  study,  it  was  not  possible  to  identify  predic-
tors  of  ED  through  the  analysis  of  logistic  regression,  as  the
number  of  COPD  patients  without  ED  was  too  small.  How-
ever,  the  univariate  analysis  of  groups  showed  that  COPD
patients  with  ED  were  signiﬁcantly  older  (p  =  0.038),  were
more  depressed  (HADS  depression  score,  p  =  0.032),  had
more  dyspnea  (mMRC  score,  p  =  0.028),  a  higher  reported
impact  of  COPD  on  their  life  (CAT  score,  p  =  0.015)  and
were  more  frequently  receiving  long  term  oxygen  therapy
(p  =  0.048).  Contrary  to  other  studies,6--8 but  in  line  with
Collins  et  al.5 we  found  no  signiﬁcant  association  between
the  percent  predicted  FEV1  and  ED.
The  effect  of  age  on  ED  is  well  known,18 so  it  was  not
surprising  that  COPD  patients  with  ED  were  older.  However,
age  by  itself  may  not  justify  the  high  prevalence  of  ED  among
COPD  patients.  For  instance,  Collins  et  al.  showed  that,  at  a
similar  age,  ED  is  worse  in  COPD  patients  than  in  the  general
population.5
The  association  between  ED  and  depression  among  COPD
patients  has  been  previously  described,  but  other  depression
b
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cales  were  used,  such  as  the  Geriatric  Depression  Scale  and
he  Beck  scale.5,6 Depression  can  impair  erectile  function
y  reducing  libido  and  by  interfering  with  the  parasym-
athetic  relaxation  of  penile  smooth  muscle  necessary  for
rection.4,22 Moreover,  the  relationship  between  depression
nd  ED  could  be  two-way  and  mutually  reinforcing.5
Our  study  also  conﬁrmed  the  impact  of  a  higher  mMRC
core  in  ED,  described  by  Turan  et  al.23 The  energy  spent
uring  an  orgasm  is  equal  to  the  energy  required  for  contin-
ous  stair  climbing  for  3--4  minutes5 so,  many  COPD  patients
ay  avoid  sexual  activity  because  of  the  dyspnea  associated
ith  this  activity.
The median  CAT  score  of  COPD  patients  with  ED
as  twice  the  median  score  of  patients  with  no  ED.
oreover,  CAT  score  was  independently  associated  to  a  mild-
oderate/moderate  ED.  As  far  as  we  know,  this  is  the  ﬁrst
tudy  to  evaluate  the  association  of  CAT  score  and  ED.  Nev-
rtheless,  it  seems  logical  that  ED  may  be  more  frequent  in
atients  in  whom  COPD  symptoms  had  a  greater  impact  on
heir  life.
A  curious  ﬁnding  was  that  COPD  patients  with  ED
ere  receiving  long  term  oxygen  therapy  more  fre-
uently  than  patients  without  ED.  It  is  known  that  chronic
ypoxia  decreases  testosterone  levels  and  impairs  nitric
xide  synthesis,  which  subsequently  reduces  the  func-
ional  integrity  of  penile  smooth  muscles.16,24 However,  it
as  demonstrated  that  reversal  of  ED  can  be  achieved  in
atients  receiving  long-term  oxygen  therapy24 but  we  can-
ot  guarantee  oxygen  therapy  compliance  of  the  included
atients,  and  the  lack  of  compliance  may  have  created  a
ias.
Patient  medication  can  contribute  to  ED,  mainly  drugs
sed  to  treat  cardiac  comorbidities.25 In  our  study,  61%
f  the  patients  were  not  taking  any  medication  associ-
ted  to  ED  and  for  the  patients  who  took  these  drugs,
here  was  no  statistical  difference  between  patients  with
D  and  without  ED.  Nevertheless,  all  patients  treated  with
eta-blockers,  digoxin,  verapamil  and  selective  serotonin
euptake  inhibitor  had  some  degree  of  ED.  Therefore,  we
annot  guarantee  there  was  no  contribution  of  these  drugs
o  prevalence  of  ED.
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Neither  the  CAT  score  nor  the  mMRC  score  evaluate
yspnea  during  sexual  activity.10,11 We  found  that  most  of
he  COPD  patients  felt  that  dyspnea  affects  their  sexual
ctivity  and  39%  reported  that  it  happened  often  or  fre-
uently.  On  the  other  hand,  patients  seldom  discuss  this
exual  problem  with  their  partner  and  only  one  in  four
atients  had  talked  about  this  issue  with  their  physicians.
his  probably  happens  because  both  patients  and  physi-
ians  feel  uncomfortable  discussing  this  topic.  However,
revious  studies  suggested  that  an  open  discussion  of  sex-
ality  with  patients  with  chronic  diseases  can  improve
heir  quality  of  life.26,27 Moreover,  sexual  problems  cannot
e  treated  until  they  are  diagnosed.  So  an  open  commu-
ication  between  physicians  and  patients  is  fundamental
or  a  successful  therapeutic  strategy.  Besides  that,  it  is
undamental  to  train  the  doctors  on  how  to  take  sex-
al  history  from  COPD  patients  and  manage  their  sexual
roblems.
The  major  strengths  of  our  study  were  the  analysis
f  multiple  demographic  and  clinical  characteristics  that
ere  prospectively  collected  and  the  use  of  a  validated
nd  internationally  used  instrument  (IIEF-5)  to  estimate  the
revalence  and  severity  of  ED.
However,  our  study  has  some  limitations.  First,  the  group
f  COPD  GOLD  D patients  is  overrepresented,  so  the  gener-
lization  of  the  conclusions  of  this  study  for  the  other  groups
hould  be  made  with  caution.  Second,  we  did  not  measure
he  sexual  hormones,  and  consequently  we  did  not  rule  out
ypogonadism  which  is  a  rare  cause  of  ED.25 Finally,  the
xclusion  of  patients  who  had  had  no  sexual  activity  in  the
revious  6  months  may  have  underestimated  the  ED  preva-
ence,  as  men  without  sexual  activity  may  have  a  higher  ED
ate.18
Further  larger  studies  are  needed  to  validate  our  ﬁndings
nd  to  contribute  to  the  identiﬁcation  of  mechanisms  of  ED
mong  COPD  patients  and  consequently  to  the  development
f  preventive  and  curative  treatments.
onclusions
his  study  highlights  the  high  prevalence  of  ED  among
atients  with  COPD  and  the  impact  of  dyspnea  in
heir  sexual  activity.  Nevertheless,  sexual  problems  are
ot  a  topic  commonly  discussed  between  patients  and
hysicians.
Physicians  should  keep  in  mind  that  COPD  patients  need  a
omprehensive  evaluation,  including  sexual  function.  COPD
uidelines  should  pay  more  attention  to  the  impact  of  this
isease  in  sexual  activity  and  include  a  consensus  document
ith  sexual  counseling  for  these  patients,  as  already  hap-
ens  with  other  diseases.28
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